Bavarian Nordic's partner Eurofarma has submitted an application to Brazil's health authority Anvisa for approval of the chikungunya vaccine CHIKV VLP, targeting prevention in people aged 12 and above. This marks a key step in making the vaccine available in Brazil, a country heavily affected by chikungunya, which causes severe joint pain and chronic arthritis in many cases. The vaccine, already approved in the US, Europe, UK, Switzerland, and Canada, is a single-dose, non-infectious vaccine designed to quickly trigger immunity. Eurofarma will handle regulatory, commercialization, and distribution activities in Brazil, while Bavarian Nordic remains the producer. The approval process is expected to advance efforts to control chikungunya's spread and impact in the region.
Birchcliff Energy shows strong operational efficiency and decent production growth, but its stock price remains stagnant. The company faces significant profit pressure from volatile and low AECO natural gas prices. Marketing strategy shortcomings als...
On August 21, 2026, the Secret Network (SCRT) community approved a proposal that increased the token supply from 362 million to over 1.44 billion, diluting existing holders' shares to about 25%. This was a planned governance decision, not a hack or f...
In Q2 2026, fund managers rotated investments from technology stocks into financials, driven by rising interest rates that benefited banks and insurers. Tech stocks and REITs faced net selling due to sensitivity to rates and AI-related market volatil...
NIU Technologies reported disappointing Q2 FY2026 earnings, with profits declining due to multiple factors, although sales are on track to set new records by the end of the fiscal year. The earnings drop is seen as temporary, and the company is expec...
Power Solutions International (PSIX) is rated as a Buy due to its ongoing transformation and operational improvements despite facing temporary production challenges. The company shows strong cash flow and management expects stronger sales in the seco...
